Editorial
doi: 10.1002/ana.10259.
Blockade of blocking antibodies in Guillain-Barré syndromes: "unblocking" the mystery of action of intravenous immunoglobulin
- PMID: 12112069
- DOI: 10.1002/ana.10259
Item in Clipboard
Editorial
Blockade of blocking antibodies in Guillain-Barré syndromes: "unblocking" the mystery of action of intravenous immunoglobulin
Ann Neurol.
2002 Jun.
No abstract available
Comment on
-
Intravenous immunoglobulins neutralize blocking antibodies in Guillain-Barré syndrome.Ann Neurol. 2002 Jun;51(6):673-80. doi: 10.1002/ana.10205. Ann Neurol. 2002. PMID: 12112071
Similar articles
-
Intravenous immunoglobulins neutralize blocking antibodies in Guillain-Barré syndrome.Ann Neurol. 2002 Jun;51(6):673-80. doi: 10.1002/ana.10205. Ann Neurol. 2002. PMID: 12112071
-
Immunoglobulin G Fc N-glycosylation in Guillain-Barré syndrome treated with intravenous immunoglobulin.Clin Exp Immunol. 2014 Dec;178 Suppl 1(Suppl 1):105-7. doi: 10.1111/cei.12530. Clin Exp Immunol. 2014. PMID: 25546781 Free PMC article. No abstract available.
-
GQ1b antibody testing in Guillain-Barre syndrome and variants.Semin Ophthalmol. 2006 Oct-Dec;21(4):223-7. doi: 10.1080/08820530601006775. Semin Ophthalmol. 2006. PMID: 17182410
-
Therapeutic strategies in the Guillain-Barré syndrome.Semin Neurol. 2003 Jun;23(2):159-68. doi: 10.1055/s-2003-41132. Semin Neurol. 2003. PMID: 12894381 Review.
-
Fc receptors for immunoglobulin G--a role in the pathogenesis of Guillain-Barré syndrome and multiple sclerosis.J Neuroimmunol. 2001 Aug 30;118(2):187-93. doi: 10.1016/s0165-5728(01)00344-7. J Neuroimmunol. 2001. PMID: 11498253 Review.
Cited by
-
Mechanistic effects of IVIg in neuroinflammatory diseases: conclusions based on clinicopathologic correlations.J Clin Immunol. 2014 Jul;34 Suppl 1:S120-6. doi: 10.1007/s10875-014-0024-5. Epub 2014 Apr 11. J Clin Immunol. 2014. PMID: 24722854 Review.
-
Therapeutic Potential of Intravenous Immunoglobulin in Acute Brain Injury.Front Immunol. 2017 Jul 31;8:875. doi: 10.3389/fimmu.2017.00875. eCollection 2017. Front Immunol. 2017. PMID: 28824617 Free PMC article. Review.
-
Anti-Neuronal Antibodies Within the IVIg Preparations: Importance in Clinical Practice.Neurotherapeutics. 2020 Jan;17(1):235-242. doi: 10.1007/s13311-019-00796-3. Neurotherapeutics. 2020. PMID: 31673865 Free PMC article.
-
Abstracts of the 13th Meeting of the European Neurological Society. 14-18 June 2003, Istanbul, Turkey.J Neurol. 2003 May;250 Suppl 2:II1-224. J Neurol. 2003. PMID: 12868443 No abstract available.
-
Update on Intravenous Immunoglobulin in Neurology: Modulating Neuro-autoimmunity, Evolving Factors on Efficacy and Dosing and Challenges on Stopping Chronic IVIg Therapy.Neurotherapeutics. 2021 Oct;18(4):2397-2418. doi: 10.1007/s13311-021-01108-4. Epub 2021 Nov 11. Neurotherapeutics. 2021. PMID: 34766257 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
